Diagnosis and Treatment of Acute Otitis Media: Evaluating the Evidence

Infectious Disease Clinics of North America

Volumn 21, Issue 2, 2007, Pages 409-426

  Powers, John H ^a,b,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEPHALOSPORIN; ERYTHROMYCIN; GATIFLOXACIN; PENICILLIN G; PLACEBO; QUINOLONE DERIVATIVE; SULFANILAMIDE DERIVATIVE;

ACUTE OTITIS MEDIA; BACTERIAL INFECTION; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; FOOD AND DRUG ADMINISTRATION; HOST RESISTANCE; HUMAN; LOW DRUG DOSE; META ANALYSIS; MYRINGOTOMY; NONHUMAN; OTALGIA; OUTCOME ASSESSMENT; QUALITY OF LIFE; RASH; RECURRENT DISEASE; REVIEW; STREPTOCOCCUS PNEUMONIA; SUPPURATIVE OTITIS MEDIA; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOMITING; WATCHFUL WAITING;

ACUTE DISEASE; HUMANS; OTITIS MEDIA;

EID: 34249886314     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.03.013     Document Type: Review

References (73)

1. Hendley J.O. Clinical practice. Otitis media. N Engl J Med 347 (2002) 1169-1174
2. Anderson J.R., Madans J.H., Feldman J.J., et al. Vital and health statistics: advance data from vital and health statistics numbers 211-220. Centers for Disease Control and Prevention (1995). http://www.cdc.gov/nchs/data/series/sr_16/sr16_022.pdf Accessed May 16, 2007
3. Froom J., Culpepper L., Jacobs M., et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 315 (1997) 98-102
4. McCaig L.F., Besser R.E., and Hughes J.M. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 287 (2002) 3096-3102
5. Boccazzi A., and Careddu P. Acute otitis media in pediatrics: are there rational issues for empiric therapy?. Pediatr Infect Dis J 16 (1997) S65-S69
6. Gates G.A. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg 114 (1996) 525-530
7. Chan L.S., Takata G.S., Shekelle P., et al. Evidence assessment of management of acute otitis media: II. Research gaps and priorities for future research. Pediatrics 108 (2001) 248-254
8. Metlay J.P., Shea J.A., Crossette L.B., et al. Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med 17 (2002) 87-94
9. Cohet C., Cheng S., MacDonald C., et al. Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J Epidemiol Community Health 58 (2004) 852-857
10. Hong L., Levy S.M., Warren J.J., et al. Association of amoxicillin use during early childhood with developmental tooth enamel defects. Arch Pediatr Adolesc Med 159 (2005) 943-948
11. Noverr M.C., Noggle R.M., Toews G.B., et al. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun 72 (2004) 4996-5003
12. Wickens K., Pearce N., Crane J., et al. Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy 29 (1999) 766-771
13. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 113 (2004) 1451-1465
14. Heikkinen T., and Ruuskanen O. Signs and symptoms predicting acute otitis media. Arch Pediatr Adolesc Med 149 (1995) 26-29
15. Ingvarsson L. Acute otalgia in children-findings and diagnosis. Acta Paediatr Scand 71 (1982) 705-710
16. Karma P.H., Penttila M.A., Sipila M.M., et al. Otoscopic diagnosis of middle ear effusion in acute and non-acute otitis media. I. The value of different otoscopic findings. Int J Pediatr Otorhinolaryngol 17 (1989) 37-49
17. Kontiokari T., Koivunen P., Niemela M., et al. Symptoms of acute otitis media. Pediatr Infect Dis J 17 (1998) 676-679
18. McCormick D.P., Lim-Melia E., Saeed K., et al. Otitis media: can clinical findings predict bacterial or viral etiology?. Pediatr Infect Dis J 19 (2000) 256-258
19. Niemela M., Uhari M., Jounio-Ervasti K., et al. Lack of specific symptomatology in children with acute otitis media. Pediatr Infect Dis J 13 (1994) 765-768
20. Sackett D.L. Bias in analytic research. J Chronic Dis 32 (1979) 51-63
21. Rothman R., Owens T., and Simel D.L. Does this child have acute otitis media?. JAMA 290 (2003) 1633-1640
22. Baker S.G., and Kramer B.S. A perfect correlate does not a surrogate make. BMC Med Res Methodol 3 (2003) 16
23. Bates A.S., Margolis P.A., and Evans A.T. Verification bias in pediatric studies evaluating diagnostic tests. J Pediatr 122 (1993) 585-590
24. Hayden G.F. Acute suppurative otitis media in children. Diversity of clinical diagnostic criteria. Clin Pediatr (Phila) 20 (1981) 99-104
25. Chandler S.M., Garcia S.M., and McCormick D.P. Consistency of diagnostic criteria for acute otitis media: a review of the recent literature. Clin Pediatr (Phila) 46 (2007) 99-108
26. Hoberman A., Marchant C.D., Kaplan S.L., et al. Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila) 41 (2002) 373-390
27. Rosenfeld R.M. Diagnostic certainty for acute otitis media. Int J Pediatr Otorhinolaryngol 64 (2002) 89-95
28. Steinbach W.J., Sectish T.C., Benjamin Jr. D.K., et al. Pediatric residents' clinical diagnostic accuracy of otitis media. Pediatrics 109 (2002) 993-998
29. U.S.Government Printing Office. U.S. Code of Federal Regulations, Title 21, Part 314.126. Available at: http://a257.g.akamaitech.net/7/257/2422/10apr20061500/edocket.access.gpo.gov/cfr_2006/aprqtr/21cfr314.126.htm. Accessed May 16, 2007.
30. US Food and Drug Administration. Transcripts of the Anti-infective Drugs Advisory Committee: clinical trial design in studies of acute bacterial otitis media. Available at: http://www.fda.gov/ohrms/dockets/ac/02/transcripts/3875T2.PDF. Accessed July 11, 2002.
31. Roark R., and Berman S. Continuous twice daily or once daily amoxicillin prophylaxis compared with placebo for children with recurrent acute otitis media. Pediatr Infect Dis J 16 (1997) 376-381
32. Straetemans M., Sanders E.A., Veenhoven R.H., et al. Pneumococcal vaccines for preventing otitis media. Cochrane Database Syst Rev 1 (2004) CD001480
33. Teele D.W., Klein J.O., Word B.M., et al. Antimicrobial prophylaxis for infants at risk for recurrent acute otitis media. Vaccine 19 Suppl 1 (2000) S140-S143
34. Williams R.L., Chalmers T.C., Stange K.C., et al. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. A meta-analytic attempt to resolve the brouhaha. JAMA 270 (1993) 1344-1351
35. Bertin L., Pons G., d'Athis P., et al. A randomized, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundam Clin Pharmacol 10 (1996) 387-392
36. Rosenfeld R.M., and Kay D. Natural history of untreated otitis media. Laryngoscope 113 (2003) 1645-1657
37. Powers J.H. Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials. Pharmacotherapy 25 (2005) 109S-123S
38. Johann-Liang R., Zalkikar J., and Powers J.H. Correlation between bacteriologic and clinical endpoints in trials of acute otitis media. Pediatr Infect Dis J 22 (2003) 936-937
39. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
40. McCormick D.P., Chonmaitree T., Pittman C., et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics 115 (2005) 1455-1465
41. Juni P., Altman D.G., and Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323 (2001) 42-46
42. Bender R., and Lange S. Adjusting for multiple testing-when and how?. J Clin Epidemiol 54 (2001) 343-349
43. Damoiseaux R.A., van Balen F.A., Hoes A.W., et al. Antibiotic treatment of acute otitis media in children under two years of age: evidence based?. Br J Gen Pract 48 (1998) 1861-1864
44. Delmar M.C., Glasziou P., and Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 314 (1997) 1526-1529
45. Marcy M., Takata G., Chan L.S., et al. Management of acute otitis media. Evid Rep Technol Assess (Summ) 15 (2000) 1-4
46. Rosenfeld R.M., Vertrees J.E., Carr J., et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 124 (1994) 355-367
47. Rovers M.M., Glasziou P., Appelman C.L., et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet 368 (2006) 1429-1435
48. Wald E.R. Acute otitis media: more trouble with the evidence. Pediatr Infect Dis J 22 (2003) 103-104
49. Bailar III J.C. The promise and problems of meta-analysis. N Engl J Med 337 (1997) 559-561
50. LeLorier J., Gregoire G., Benhaddad A., et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337 (1997) 536-542
51. Anello C., and Fleiss J.L. Exploratory or analytic meta-analysis: should we distinguish between them?. J Clin Epidemiol 48 (1995) 109-116
52. Appelman C.L., Claessen J.Q., Touw-Otten F.W., et al. Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ 303 (1991) 1450-1452
53. Burke P., Bain J., Robinson D., et al. Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ 303 (1991) 558-562
54. Damoiseaux R.A., van Balen F.A., Hoes A.W., et al. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 320 (2000) 350-354
55. Halsted C., Lepow M.L., Balassanian N., et al. Otitis media. Clinical observations, microbiology, and evaluation of therapy. Am J Dis Child 115 (1968) 542-551
56. Howie V.M., and Ploussard J.H. Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolate- triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clin Pediatr (Phila) 11 (1972) 205-214
57. Kaleida P.H., Casselbrant M.L., Rockette H.E., et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 87 (1991) 466-474
58. Laxdal O.E., Merida J., and Jones R.H. Treatment of acute otitis media: a controlled study of 142 children. Can Med Assoc J 102 (1970) 263-268
59. LeSaux S.N., Gaboury I., Baird M., et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. CMAJ 172 (2005) 335-341
60. Mygind N., Meistrup-Larsen K.I., Thomsen J., et al. Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clin Otolaryngol Allied Sci 6 (1981) 5-13
61. Thalin A, Densert O, Larsson A, Is penicillin necessary in the treatment of acute otitis media? Proceedings of the international conference on acute and secretory otitis media Part 1, 441-446. 1986.
62. van Buchem F.L., Dunk J.H., and van't Hof M.A. Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children. Lancet 2 (1981) 883-887
63. Little P., Gould G., Williamson I., et al. Pragmatic randomised controlled trial of two prescribing strategies for childhood otitis media. BMJ 322 (2001) 336-342
64. Siegel R.M., Kiely M., Bien J.P., et al. Treatment of otitis media with observation and safety-net antibiotic prescription. Pediatrics 112 (2003) 527-531
65. Cates C. An evidence based approach to reducing antibiotic prescribing use in children with acute otitis media: controlled before and after study. BMJ 318 (1999) 715-716
66. Powers J.H. Interpreting the results of clinical trials on antimicrobial agents. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 6th edition (2005), Elsevier Churchill Livingstone, Philadelphia 619-628
67. Pocock S.J. The pros and cons of noninferiority trials. Fundam Clin Pharmacol 17 (2003) 483-490
68. Augmentin ES-600 prescription drug labeling. In: Physicians desk reference. Monvale (NJ): Thomson Scientific; 2007.
69. Saez-Llorens X., Rodriguez A., Arguedas A., et al. Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children. Pediatr Infect Dis J 24 (2005) 293-300
70. World Medical Association. Declaration of Helsinki. Available at: http://www.wma.net/e/policy/b3.htm. Accessed May 16, 2007.
71. International Conference on Harmonisation. Choice of control group and related issues in clinical trials (ICH E-10). 2006.
72. International Conference on Harmonisation. Statistical principles for clinical trials (ICH E-9). Available at: http://www.ich.org/MediaServer.jser?@_ID=485&@_MODE=GLB. 2006. Accessed May 16, 2007.
73. Siegel R.M., Bien J., Lichtenstein P., et al. A safety-net antibiotic prescription for otitis media: the effects of a PBRN study on patients and practitioners. Clin Pediatr (Phila) 45 (2006) 518-524